The presence of IDH1/IDH2 mutations helps distinguish CS from chondroblastic osteosarcoma and DDCS from undifferentiated pleomorphic sarcoma (UPS) of bone (9, 10). This evidence concerns the gene IDH1 and Cowden syndrome 1.